Non-interventional Prospective Observational Study of Cytoflavin in Combination With Reperfusion in Stroke Patients
Condition: Acute Stroke Interventions: Drug: Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin); Drug: Control Sponsor: POLYSAN Scientific& Technological Pharmaceutical Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2022 Category: Research Source Type: clinical trials
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution; Other: Standard of Care Therapy + Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials